Market Overview

Research and Markets: Canada Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery

Share:
DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/2p4chl/canada_diabetes) has announced the addition of GlobalData's new report "Canada Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery" to their offering.

The new report, Canada Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery provides key market data on the Canada Diabetes Care Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories - Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

Scope

- Market size and company share data for Diabetes Care Devices market categories - Glucose Monitoring and Insulin Delivery.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within two market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the two market categories.

- Global corporate-level profiles of key companies operating within the Canada Diabetes Care Devices market.

- Key players covered include Bayer HealthCare AG, LifeScan, Inc., F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Abbott Laboratories, Novo Nordisk A/S and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the Canada Diabetes Care Devices competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

Companies Mentioned

Bayer HealthCare AG

LifeScan, Inc.

F. Hoffmann-La Roche Ltd.

Eli Lilly and Company

Abbott Laboratories

Novo Nordisk A/S

Becton, Dickinson and Company

Sanofi

Medtronic, Inc.

Animas Corporation

For more information visit http://www.researchandmarkets.com/research/2p4chl/canada_diabetes

Source: GlobalData

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Medical Devices




View Comments and Join the Discussion!